These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 33550042)
21. The Advances of the Structure and Function of Indoleamine 2, 3- dioxygenase 1 and Its Inhibitors. Duan HC; Peng LX; Hu YC; Luo Q; Liu XY; Sun X; Liang L; Gan Y; Liu W; Wan H; Shi HB; Zhao G; Hu JP Curr Protein Pept Sci; 2020; 21(10):1027-1039. PubMed ID: 32452326 [TBL] [Abstract][Full Text] [Related]
22. Marine natural products and other derivatives as potent indoleamine 2,3-dioxygenase inhibitors. Delfourne E Mini Rev Med Chem; 2012 Sep; 12(10):988-96. PubMed ID: 22512584 [TBL] [Abstract][Full Text] [Related]
23. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598 [TBL] [Abstract][Full Text] [Related]
24. Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase. Winters M; DuHadaway JB; Pham KN; Lewis-Ballester A; Badir S; Wai J; Sheikh E; Yeh SR; Prendergast GC; Muller AJ; Malachowski WP Eur J Med Chem; 2019 Jan; 162():455-464. PubMed ID: 30469041 [TBL] [Abstract][Full Text] [Related]
25. Investigation of the Tissue Distribution and Physiological Roles of Indoleamine 2,3-Dioxygenase-2. Jusof FF; Bakmiwewa SM; Weiser S; Too LK; Metz R; Prendergast GC; Fraser ST; Hunt NH; Ball HJ Int J Tryptophan Res; 2017; 10():1178646917735098. PubMed ID: 29051706 [TBL] [Abstract][Full Text] [Related]
26. Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer. Prendergast GC; Malachowski WJ; Mondal A; Scherle P; Muller AJ Int Rev Cell Mol Biol; 2018; 336():175-203. PubMed ID: 29413890 [TBL] [Abstract][Full Text] [Related]
27. Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors. Meininger D; Zalameda L; Liu Y; Stepan LP; Borges L; McCarter JD; Sutherland CL Biochim Biophys Acta; 2011 Dec; 1814(12):1947-54. PubMed ID: 21835273 [TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling. Yamamoto Y; Yamasuge W; Imai S; Kunisawa K; Hoshi M; Fujigaki H; Mouri A; Nabeshima T; Saito K Sci Rep; 2018 Oct; 8(1):15917. PubMed ID: 30374077 [TBL] [Abstract][Full Text] [Related]
29. Indoleamine 2, 3-dioxygenase regulation of immune response (Review). Wu H; Gong J; Liu Y Mol Med Rep; 2018 Apr; 17(4):4867-4873. PubMed ID: 29393500 [TBL] [Abstract][Full Text] [Related]
30. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Metz R; Duhadaway JB; Kamasani U; Laury-Kleintop L; Muller AJ; Prendergast GC Cancer Res; 2007 Aug; 67(15):7082-7. PubMed ID: 17671174 [TBL] [Abstract][Full Text] [Related]
31. Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy. He X; He G; Chu Z; Wu H; Wang J; Ge Y; Shen H; Zhang S; Shan J; Peng K; Wei Z; Zou Y; Xu Y; Zhu Q J Med Chem; 2021 Dec; 64(24):17950-17968. PubMed ID: 34854662 [TBL] [Abstract][Full Text] [Related]
32. 1-L-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-D-methyltryptophan. Yuasa HJ; Ball HJ; Austin CJ; Hunt NH Comp Biochem Physiol B Biochem Mol Biol; 2010 Sep; 157(1):10-5. PubMed ID: 20399882 [TBL] [Abstract][Full Text] [Related]
33. Targeting the IDO1 pathway in cancer: from bench to bedside. Liu M; Wang X; Wang L; Ma X; Gong Z; Zhang S; Li Y J Hematol Oncol; 2018 Aug; 11(1):100. PubMed ID: 30068361 [TBL] [Abstract][Full Text] [Related]
34. Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy. Yentz S; Smith D BioDrugs; 2018 Aug; 32(4):311-317. PubMed ID: 29980987 [TBL] [Abstract][Full Text] [Related]
35. Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool. Mandarano M; Bellezza G; Belladonna ML; Vannucci J; Gili A; Ferri I; Lupi C; Ludovini V; Falabella G; Metro G; Mondanelli G; Chiari R; Cagini L; Stracci F; Roila F; Puma F; Volpi C; Sidoni A Front Immunol; 2020; 11():839. PubMed ID: 32536910 [TBL] [Abstract][Full Text] [Related]